Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

Similar articles for PubMed (Select 12023629)

1.

Tolerance to vascularized kidney grafts in canine mixed hematopoietic chimeras.

Kuhr CS, Allen MD, Junghanss C, Zaucha JM, Marsh CL, Yunusov M, Zellme E, Little MT, Torok-Storb B, Storb R.

Transplantation. 2002 May 15;73(9):1487-92.

PMID:
12023629
2.

Long-term tolerance to kidney allografts after induced rejection of donor hematopoietic chimerism in a preclinical canine model.

Graves SS, Mathes DW, Georges GE, Kuhr CS, Chang J, Butts TM, Storb R.

Transplantation. 2012 Sep 27;94(6):562-8.

3.

Adoptive immunotherapy against kidney targets in dog-leukocyte antigen-identical mixed hematopoietic canine chimeras.

Junghanss C, Takatu A, Little MT, Maciej Zaucha J, Zellmer E, Yunusov M, Sale G, Georges GE, Storb R.

Transplantation. 2003 Feb 15;75(3):268-74.

PMID:
12589144
4.

A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers.

Colson YL, Wren SM, Schuchert MJ, Patrene KD, Johnson PC, Boggs SS, Ildstad ST.

J Immunol. 1995 Nov 1;155(9):4179-88.

PMID:
7594573
5.

Adoptive immunotherapy in canine mixed chimeras after nonmyeloablative hematopoietic cell transplantation.

Georges GE, Storb R, Thompson JD, Yu C, Gooley T, Bruno B, Nash RA.

Blood. 2000 May 15;95(10):3262-9.

6.

Tolerance to vascularized composite allografts in canine mixed hematopoietic chimeras.

Mathes DW, Hwang B, Graves SS, Edwards J, Chang J, Storer BE, Butts-Miwongtum T, Sale GE, Nash RA, Storb R.

Transplantation. 2011 Dec 27;92(12):1301-8. doi: 10.1097/TP.0b013e318237d6d4.

7.

Allogeneic hematopoietic stem-cell transplantation, mixed chimerism, and tolerance in living related donor renal allograft recipients.

Trivedi HL, Vanikar AV, Modi PR, Shah VR, Vakil JM, Trivedi VB, Khemchandani SI.

Transplant Proc. 2005 Mar;37(2):737-42.

PMID:
15848518
8.

FLT3 ligand promotes engraftment of allogeneic hematopoietic stem cells without significant graft-versus-host disease.

Yunusov MY, Georges GE, Storb R, Moore P, Hagglund H, Affolter V, Lesnikova M, Gass MJ, Little MT, Loken M, McKenna H, Storer B, Nash RA.

Transplantation. 2003 Apr 15;75(7):933-40.

PMID:
12698076
9.

Hematopoietic chimerism induces renal and skin allograft tolerance in DLA-identical dogs.

Tillson M, Niemeyer GP, Welch JA, Brawner W, Swaim SF, Rynders P, Lenz SD, Dean B, Lothrop CD Jr.

Exp Hematol. 2006 Dec;34(12):1759-70.

PMID:
17157174
10.

Adoptive immunotherapy against allogeneic kidney grafts in dogs with stable hematopoietic trichimerism.

Graves SS, Hogan WJ, Kuhr C, Diaconescu R, Harkey M, Sale GE, Stone B, Georges GE, Storb R.

Biol Blood Marrow Transplant. 2008 Nov;14(11):1201-8. doi: 10.1016/j.bbmt.2008.08.005.

11.

Tacrolimus-based partial conditioning produces stable mixed lymphohematopoietic chimerism and tolerance for cardiac allografts.

Gammie JS, Li S, Zeevi A, Demetris AJ, Ildstad ST, Pham SM.

Circulation. 1998 Nov 10;98(19 Suppl):II163-8; discussion II168-9.

PMID:
9852899
12.

IL-2 does not enhance the conversion to complete donor chimerism following nonmyeloablative hematopoietic cell transplantation in dogs.

Georges GE, Storb R, Maciej Zaucha J, Taranova AG, Gooley T, Nash RA.

Bone Marrow Transplant. 2003 Jun;31(11):1027-31.

PMID:
12774055
13.

Stable trichimerism after marrow grafting from 2 DLA-identical canine donors and nonmyeloablative conditioning.

Graves SS, Hogan W, Kuhr CS, Diaconescu R, Harkey MA, Georges GE, Sale GE, Zellmer E, Baran SW, Jochum C, Stone B, Storb R.

Blood. 2007 Jul 1;110(1):418-23. Epub 2007 Mar 16. Erratum in: Blood. 2010 Feb 11;115(6):1313. Baran, Szczepan [corrected to Baran, Szczepan W].

14.

Simultaneous transplantation of hematopoietic stem cells and a vascularized composite allograft leads to tolerance.

Mathes DW, Chang J, Hwang B, Graves SS, Storer BE, Butts-Miwongtum T, Sale GE, Storb R.

Transplantation. 2014 Jul 27;98(2):131-8. doi: 10.1097/TP.0000000000000204.

PMID:
24918616
15.

Renal allograft tolerance in DLA-identical and haploidentical dogs after nonmyeloablative conditioning and transient immunosuppression with cyclosporine and mycophenolate mofetil.

Niemeyer GP, Welch JA, Tillson M, Brawner W, Rynders P, Goodman S, Dufresne M, Dennis J, Lothrop CD Jr.

Transplant Proc. 2005 Dec;37(10):4579-86.

PMID:
16387175
16.

Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.

Strober S.

Blood Cells Mol Dis. 2008 Jan-Feb;40(1):48-54. Epub 2007 Sep 10. Review.

PMID:
17827036
18.

Immunomodulatory effects induced by cytotoxic T lymphocyte antigen 4 immunoglobulin with donor peripheral blood mononuclear cell infusion in canine major histocompatibility complex-haplo-identical non-myeloablative hematopoietic cell transplantation.

Chen Y, Fukuda T, Thakar MS, Kornblit BT, Storer BE, Santos EB, Storb R, Sandmaier BM.

Cytotherapy. 2011 Nov;13(10):1269-80. doi: 10.3109/14653249.2011.586997. Epub 2011 Aug 17.

19.

HLA identical non-chimeric and HLA disparate chimeric renal transplant tolerance.

Leventhal JR, Mathew JM, Ildstad S, Salomon DR, Kurian SM, Suthanthiran M, Tambur A, Friedewald J, Gallon L, Charette J, Levitsky J, Kanwar Y, Abecassis M, Miller J.

Clin Transpl. 2013:145-56.

PMID:
25095503
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk